Du är här


Bavarian Nordic A/S: Bavarian Nordic to Host First Quarter 2014 Results Conference Call

KVISTGAARD, Denmark - May 6, 2014
- Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2014 first
quarterly results on Wednesday, May 14, 2014.

The company will host a conference call at 2:00 pm CET (8:00 am EDT) on the
same day. President and CEO, Anders Hedegaard will present the interim
results followed by a Q&A session with participation of the Company's
executive management.

Dial-in numbers for the conference call are:
Denmark: +45 32 72 80 18
UK: +44 (0) 844 571 8957
USA: +1 866 682 8490

A webcast of the conference call will be broadcasted simultaneously
athttp://bit.ly/bava1Q2014. On this page, the accompanying presentation will
be available prior to the conference call.

U.S.: Seth Lewis, Vice President, Investor Relations. Phone: + 1 978-298-5654
Europe: Rolf Sass Sørensen, Vice President Investor Relations&Communications.
Phone +45 61 77 47 43

About Bavarian Nordic
Bavarian Nordic is an international biotechnology company developing and
manufacturing novel cancer immunotherapies and vaccines for infectious
diseases. Lead product candidates are PROSTVAC®, an immunotherapy product
candidate for advanced prostate cancer that is the subject of an ongoing
pivotal Phase 3 clinical trial and IMVAMUNE®, a non-replicating smallpox
vaccine candidate in Phase 3 development, which is being developed and
supplied for emergency use to the U.S. Strategic National Stockpile under a
contract with the U.S. Government. IMVAMUNE is approved in the European Union
under the trade name IMVANEX®.

Bavarian Nordic's shares are listed on NASDAQ OMX Copenhagen under the symbol
BAVA (Reuters: BAVA.CO, Bloomberg: BAVA.DC). The company has a sponsored
Level 1 ADR program listed in the US (OTC) under the symbol BVNRY.

For more information, visitwww.bavarian-nordic.com.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bavarian Nordic A/S via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.